Cytek Biosciences, Inc. (CTKB) NASDAQ

5.20

-0.16(-2.99%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap847.67M
Enterprise Value765.97M
P/E Ratio-102.92
PEG Ratio-2.31
Price/Sales Ratio3.39
Price/Book Ratio1.74
Enterprise/Revenue3.07
Enterprise/EBITDA-70.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.03
Operating Margin-0.14

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue200.45M
Revenue/Share1.54
Gross Profit111.11M
EBITDA-10.03M
Net Income-6.02M
Diluted EPS-0.05

Balance Sheet

Total Cash261.73M
Total Cash/Share2.06
Total Debt35.16M
Total Debt/Equity0.04
Current Ratio5.22
Book Value Per Share2.97

Price History

52-Week Change-22.42
52-Week High7.3
52-Week Low2.37
Moving Average 50 Days4.4
Moving Average 200 Days3.9

Statistics

Average Volume1.14M
Shares Outstanding127.86M
% Held by Institutions63.05

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A